UBS Group’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $179K | Buy |
|
|||||
|
2025
Q2 | $38.5K | Sell |
|
|||||
|
2025
Q1 | $349K | Buy |
|
|||||
|
2024
Q4 | $122K | Buy |
|
|||||
|
2024
Q3 | $13.9K | Buy |
|
|||||
|
2024
Q2 | $46.2K | Sell |
|
|||||
|
2024
Q1 | $132K | Sell |
|
|||||
|
2023
Q4 | $178K | Buy |
|
|||||
|
2023
Q3 | $43.2K | Sell |
|
|||||
|
2023
Q2 | $74.8K | Buy |
|
|||||
|
2023
Q1 | $11.4K | Sell |
|
|||||
|
2022
Q4 | $5.26K | Sell |
|
|||||
|
2022
Q3 | $16K | Buy |
|
|||||
|
2022
Q2 | $7K | Buy |
|
|||||
|
2022
Q1 | $23K | Sell |
|
|||||
|
2021
Q4 | $40K | Buy |
|
|||||
|
2021
Q3 | $48K | Sell |
|
|||||
|
2021
Q2 | $86K | Sell |
|
|||||
|
2021
Q1 | $150K | Buy |
|
|||||
|
2020
Q4 | $71K | Buy |
|
|||||
|
2020
Q3 | $24K | Sell |
|
|||||
|
2020
Q2 | $81K | Sell |
|
|||||
|
2020
Q1 | $120K | Sell |
|
|||||
|
2019
Q4 | $298K | Buy |
|
|||||
|
2019
Q3 | $206K | Buy |
|
|||||
|
2019
Q2 | $50K | Buy |
|
|||||
|
2019
Q1 | $24K | Sell |
|
|||||
|
2018
Q4 | $34K | Buy |
|
|||||
|
2018
Q3 | $55K | Buy |
|
|||||
|
2018
Q2 | $2K | Buy |
|